AustralianSuper’s Boston Scientific BSX Stock Holding History

AustralianSuper’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.4M	Sell	628,448 -608,743	-49%	-$48.7M	0.21%	97
2025 Q4	$118M	Sell	1,237,191 -1,509,137	-55%	-$148M	0.55%	39
2025 Q3	$268M	Buy	2,746,328 +47,473	+2%	+$4.92M	1.27%	12
2025 Q2	$290M	Sell	2,698,855 -122,742	-4%	-$12.4M	1.47%	14
2025 Q1	$285M	Buy	2,821,597 +235,322	+9%	+$23.7M	1.61%	11
2024 Q4	$231M	Sell	2,586,275 -90,572	-3%	-$7.97M	1.09%	16
2024 Q3	$224M	Buy	2,676,847 +2,615,903	+4,292%	+$206M	1.12%	21
2024 Q2	$4.69M	Hold	60,944	–	–	0.03%	147
2024 Q1	$4.15M	Sell	60,944 -12,521	-17%	-$805K	0.02%	165
2023 Q4	$4.25M	Sell	73,465 -6,175	-8%	-$330K	0.03%	175
2023 Q3	$4.2M	Buy	79,640 +3,930	+5%	+$206K	0.03%	167
2023 Q2	$4.1M	Buy	+75,710	New	+$3.95M	0.03%	181
2020 Q2	–	Sell	-221,930	Closed	-$7.24M	–	184
2020 Q1	$7.24M	Sell	221,930 -4,017,208	-95%	-$157M	0.09%	77
2019 Q4	$192M	Sell	4,239,138 -1,051,384	-20%	-$44M	1.62%	28
2019 Q3	$215M	Hold	5,290,522	–	–	2.04%	20
2019 Q2	$227M	Buy	5,290,522 +669,830	+14%	+$25.8M	2.19%	16
2019 Q1	$177M	Buy	+4,620,692	New	+$176M	1.85%	22

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AustralianSuper's BSX Position: Q1 2026 in Review

AustralianSuper reduced its Boston Scientific (BSX) stake by 49% in Q1 2026, selling an estimated $48.7M and leaving 628,448 shares worth $39.4M. The position accounts for 0.21% of the portfolio, ranked #97.

AustralianSuper first reported a position in BSX in Q1 2019 and has held it in 17 quarters since. The position peaked at $290M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

AustralianSuper held 628,448 shares of Boston Scientific worth $39.4M as of Q1 2026.
AustralianSuper sold 608,743 Boston Scientific shares in Q1 2026, an estimated $48.7M.
Boston Scientific made up 0.21% of AustralianSuper's portfolio in Q1 2026, its #97 holding.
AustralianSuper first reported a position in Boston Scientific in Q1 2019 and has held it in 17 quarters since.
AustralianSuper's Boston Scientific position peaked at $290M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.